Načítá se...
Update Breast Cancer 2019 Part 2 – Implementation of Novel Diagnostics and Therapeutics in Advanced Breast Cancer Patients in Clinical Practice
The treatment of patients with advanced breast cancer has developed further in recent years. In addition to therapeutic progress in the established subgroups (hormone receptor and HER2 status), there are now therapies which are geared to individual molecular characteristics, such as PARP inhibitor t...
Uloženo v:
| Vydáno v: | Geburtshilfe Frauenheilkd |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Georg Thieme Verlag KG
2019
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6414305/ https://ncbi.nlm.nih.gov/pubmed/30880825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/a-0842-6661 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|